Hye-Young H. Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hye-Young H. Kim has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Ilona Jaspers
University of North Carolina at Chapel Hill
3 shared publications Ned A. Porter
Vanderbilt University
3 shared publicationsNed A Porter
Department of Chemistry and Vanderbilt Institute of Chemical Biology , Vanderbilt University , Nashville, TN 37235
2 shared publications- Aiman Q. Khan
Center for Perinatal Research, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH, United States
1 shared publication Alexia Perryman
University of North Carolina at Chapel Hill
1 shared publicationArunava Ghosh
University of North Carolina at Chapel Hill
1 shared publication
Latest Publications
- 12 December 2025
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 209 (2)
7-OH and kratom vaping products: an emerging public health threat
- 12 December 2025
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 209 (2)
7-OH and kratom vaping products: an emerging public health threat
- 1 October 2025
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 329 (4) , L514-L523
Aerosolized vitamin D attenuates ozone-induced inflammation and transcriptional responses via membrane antioxidant effects in human bronchial epithelial cells
Vitamin D aerosols have the potential to protect against exposure to ozone and other inhaled oxidants and prevent the development and exacerbation of lung disease. Here, we show that aerosolized vitamin D treatment decreased ozone-induced oxidative stress and inflammatory responses, as well as decreased production of an oxysterol, β-epoxycholesterol, indicating vitamin D may act as a membrane antioxidant in the airway epithelium.
- 1 October 2025
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 329 (4) , L514-L523
Aerosolized vitamin D attenuates ozone-induced inflammation and transcriptional responses via membrane antioxidant effects in human bronchial epithelial cells
Vitamin D aerosols have the potential to protect against exposure to ozone and other inhaled oxidants and prevent the development and exacerbation of lung disease. Here, we show that aerosolized vitamin D treatment decreased ozone-induced oxidative stress and inflammatory responses, as well as decreased production of an oxysterol, β-epoxycholesterol, indicating vitamin D may act as a membrane antioxidant in the airway epithelium.
- Open Access
- 1 February 2025
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 328 (2) , L207-L214
Evidence of sex differences in ozone-induced oxysterol and cytokine levels in differentiated human nasal epithelial cells
It is increasingly recognized that lung biology and responses to pollutant exposures differ in males and females. Using a model of differentiated nasal epithelial cells from male and female donors, our data demonstrate that pollutant-induced cytokine/chemokine responses and oxidized lipid levels vary by sex, with donor-specific oxidized lipids linked to inflammatory mediator release.
- 1 February 2025
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 328 (2) , L207-L214
Open AccessEvidence of sex differences in ozone-induced oxysterol and cytokine levels in differentiated human nasal epithelial cells
It is increasingly recognized that lung biology and responses to pollutant exposures differ in males and females. Using a model of differentiated nasal epithelial cells from male and female donors, our data demonstrate that pollutant-induced cytokine/chemokine responses and oxidized lipid levels vary by sex, with donor-specific oxidized lipids linked to inflammatory mediator release.
- 12 July 2022
- Published by Wiley in The Prostate
- Vol. 82 (14) , 1378-1388
Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5‐alpha reductase inhibitor treated human benign prostate hyperplasia patients
Background: The development of benign prostatic hyperplasia (BPH) and medication‐refractory lower urinary tract symptoms (LUTS) remain poorly understood. This study attempted to characterize the pathways associated with failure of medical therapy for BPH/LUTS.Methods: Transitional zone tissue levels of cholesterol and steroids were measured in patients who failed medical therapy for BPH/LUTS and controls. Prostatic gene expression was measured using qPCR and BPH cells were used in organoid culture to study prostatic branching.Results: BPH patients on 5‐α‐reductase inhibitor (5ARI) showed low levels of tissue dihydrotestosterone (DHT), increased levels of steroid 5‐α‐reductase type II (SRD5A2), and diminished levels of androgen receptor (AR) target genes, prostate‐specific antigen (PSA), and transmembrane serine protease 2 (TMPRSS2). 5ARI raised prostatic tissue levels of glucocorticoids (GC), whereas alpha‐adrenergic receptor antagonists (α‐blockers) did not. Nuclear localization of GR in prostatic epithelium and stroma appeared in all patient samples. Treatment of four BPH organoid cell lines with dexamethasone, a synthetic GC, resulted in budding and branching.Conclusions: After failure of medical therapy for BPH/LUTS, 5ARI therapy continued to inhibit androgenesis but a 5ARI‐induced pathway increased tissue levels of GC not seen in patients on α‐blockers. GC stimulation of organoids indicated that the GC receptors are a trigger for controlling growth of prostate glands. A 5ARI‐induced pathway revealed GC activation can serve as a master regulator of prostatic branching and growth.
- 12 July 2022
- Published by Wiley in The Prostate
- Vol. 82 (14) , 1378-1388
Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5‐alpha reductase inhibitor treated human benign prostate hyperplasia patients
Background: The development of benign prostatic hyperplasia (BPH) and medication‐refractory lower urinary tract symptoms (LUTS) remain poorly understood. This study attempted to characterize the pathways associated with failure of medical therapy for BPH/LUTS.Methods: Transitional zone tissue levels of cholesterol and steroids were measured in patients who failed medical therapy for BPH/LUTS and controls. Prostatic gene expression was measured using qPCR and BPH cells were used in organoid culture to study prostatic branching.Results: BPH patients on 5‐α‐reductase inhibitor (5ARI) showed low levels of tissue dihydrotestosterone (DHT), increased levels of steroid 5‐α‐reductase type II (SRD5A2), and diminished levels of androgen receptor (AR) target genes, prostate‐specific antigen (PSA), and transmembrane serine protease 2 (TMPRSS2). 5ARI raised prostatic tissue levels of glucocorticoids (GC), whereas alpha‐adrenergic receptor antagonists (α‐blockers) did not. Nuclear localization of GR in prostatic epithelium and stroma appeared in all patient samples. Treatment of four BPH organoid cell lines with dexamethasone, a synthetic GC, resulted in budding and branching.Conclusions: After failure of medical therapy for BPH/LUTS, 5ARI therapy continued to inhibit androgenesis but a 5ARI‐induced pathway increased tissue levels of GC not seen in patients on α‐blockers. GC stimulation of organoids indicated that the GC receptors are a trigger for controlling growth of prostate glands. A 5ARI‐induced pathway revealed GC activation can serve as a master regulator of prostatic branching and growth.
- Open Access
- 14 March 2022
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 208 (7) , 1525-1533
PRMT5 in T Cells Drives Th17 Responses, Mixed Granulocytic Inflammation, and Severe Allergic Airway Inflammation
Severe asthma is characterized by steroid insensitivity and poor symptom control and is responsible for most asthma-related hospital costs. Therapeutic options remain limited, in part due to limited understanding of mechanisms driving severe asthma. Increased arginine methylation, catalyzed by protein arginine methyltransferases (PRMTs), is increased in human asthmatic lungs. In this study, we show that PRMT5 drives allergic airway inflammation in a mouse model reproducing multiple aspects of human severe asthma. We find that PRMT5 is required in CD4+ T cells for chronic steroid-insensitive severe lung inflammation, with selective T cell deletion of PRMT5 robustly suppressing eosinophilic and neutrophilic lung inflammation, pathology, airway remodeling, and hyperresponsiveness. Mechanistically, we observed high pulmonary sterol metabolic activity, retinoic acid-related orphan receptor γt (RORγt), and Th17 responses, with PRMT5-dependent increases in RORγt’s agonist desmosterol. Our work demonstrates that T cell PRMT5 drives severe allergic lung inflammation and has potential implications for the pathogenesis and therapeutic targeting of severe asthma.
- 14 March 2022
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 208 (7) , 1525-1533
Open AccessPRMT5 in T Cells Drives Th17 Responses, Mixed Granulocytic Inflammation, and Severe Allergic Airway Inflammation
Severe asthma is characterized by steroid insensitivity and poor symptom control and is responsible for most asthma-related hospital costs. Therapeutic options remain limited, in part due to limited understanding of mechanisms driving severe asthma. Increased arginine methylation, catalyzed by protein arginine methyltransferases (PRMTs), is increased in human asthmatic lungs. In this study, we show that PRMT5 drives allergic airway inflammation in a mouse model reproducing multiple aspects of human severe asthma. We find that PRMT5 is required in CD4+ T cells for chronic steroid-insensitive severe lung inflammation, with selective T cell deletion of PRMT5 robustly suppressing eosinophilic and neutrophilic lung inflammation, pathology, airway remodeling, and hyperresponsiveness. Mechanistically, we observed high pulmonary sterol metabolic activity, retinoic acid-related orphan receptor γt (RORγt), and Th17 responses, with PRMT5-dependent increases in RORγt’s agonist desmosterol. Our work demonstrates that T cell PRMT5 drives severe allergic lung inflammation and has potential implications for the pathogenesis and therapeutic targeting of severe asthma.
- Open Access
- 10 January 2022
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 12, 799096
Expressing the Human Cholesteryl Ester Transfer Protein Minigene Improves Diet-Induced Fatty Liver and Insulin Resistance in Female Mice
Mounting evidence has shown that CETP has important physiological roles in adapting to chronic nutrient excess, specifically, to protect against diet-induced insulin resistance. However, the underlying mechanisms for the protective roles of CETP in metabolism are not yet clear. Mice naturally lack CETP expression. We used transgenic mice with a human CETP minigene (huCETP) controlled by its natural flanking region to further understand CETP-related physiology in response to obesity. Female huCETP mice and their wild-type littermates were fed a high-fat diet for 6 months. Blood lipid profile and liver lipid metabolism were studied. Insulin sensitivity was analyzed with euglycemic-hyperinsulinemic clamp studies combined with 3H-glucose tracer techniques. While high-fat diet feeding induced obesity for huCETP mice and their wild-type littermates lacking CETP expression, insulin sensitivity was higher for female huCETP mice than for their wild-type littermates. There was no difference in insulin sensitivity for male huCETP mice vs. littermates. The increased insulin sensitivity in females was largely caused by the better insulin-mediated suppression of hepatic glucose production. In huCETP females, CETP in the circulation decreased HDL-cholesterol content and increased liver cholesterol uptake and liver cholesterol and oxysterol contents, which was associated with the upregulation of LXR target genes in long-chain polyunsaturated fatty acid biosynthesis and PPARα target genes in fatty acid β-oxidation in the liver. The upregulated fatty acid β-oxidation may account for the improved fatty liver and liver insulin action in female huCETP mice. This study provides further evidence that CETP has beneficial physiological roles in the metabolic adaptation to nutrient excess by promoting liver fatty acid oxidation and hepatic insulin sensitivity, particularly for females.
- 10 January 2022
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 12, 799096
Open AccessExpressing the Human Cholesteryl Ester Transfer Protein Minigene Improves Diet-Induced Fatty Liver and Insulin Resistance in Female Mice
Mounting evidence has shown that CETP has important physiological roles in adapting to chronic nutrient excess, specifically, to protect against diet-induced insulin resistance. However, the underlying mechanisms for the protective roles of CETP in metabolism are not yet clear. Mice naturally lack CETP expression. We used transgenic mice with a human CETP minigene (huCETP) controlled by its natural flanking region to further understand CETP-related physiology in response to obesity. Female huCETP mice and their wild-type littermates were fed a high-fat diet for 6 months. Blood lipid profile and liver lipid metabolism were studied. Insulin sensitivity was analyzed with euglycemic-hyperinsulinemic clamp studies combined with 3H-glucose tracer techniques. While high-fat diet feeding induced obesity for huCETP mice and their wild-type littermates lacking CETP expression, insulin sensitivity was higher for female huCETP mice than for their wild-type littermates. There was no difference in insulin sensitivity for male huCETP mice vs. littermates. The increased insulin sensitivity in females was largely caused by the better insulin-mediated suppression of hepatic glucose production. In huCETP females, CETP in the circulation decreased HDL-cholesterol content and increased liver cholesterol uptake and liver cholesterol and oxysterol contents, which was associated with the upregulation of LXR target genes in long-chain polyunsaturated fatty acid biosynthesis and PPARα target genes in fatty acid β-oxidation in the liver. The upregulated fatty acid β-oxidation may account for the improved fatty liver and liver insulin action in female huCETP mice. This study provides further evidence that CETP has beneficial physiological roles in the metabolic adaptation to nutrient excess by promoting liver fatty acid oxidation and hepatic insulin sensitivity, particularly for females.
- Open Access
- 31 December 2016
- Published by The Korean Magnetics Society in Journal of Magnetics
- Vol. 21 (4) , 599-602
Hard Tissue Analysis of NMR after Fluoride Administration
- 31 December 2016
- Published by The Korean Magnetics Society in Journal of Magnetics
- Vol. 21 (4) , 599-602
Open AccessHard Tissue Analysis of NMR after Fluoride Administration
- Open Access
- 1 January 2008
- Published by The Korean Society for Microbiology and The Korean Society of Virology in Journal of Bacteriology and Virology
- Vol. 38 (4) , 249-257
Molecular Epidemiologic Investigation of Norovirus Infections in Incheon City, Korea, from 2005 to 2007
Gong YW, et al. J Bacteriol Virol. 2008 Dec;38(4):249-257. http://dx.doi.org/10.4167/jbv.2008.38.4.249
- 1 January 2008
- Published by The Korean Society for Microbiology and The Korean Society of Virology in Journal of Bacteriology and Virology
- Vol. 38 (4) , 249-257
Open AccessMolecular Epidemiologic Investigation of Norovirus Infections in Incheon City, Korea, from 2005 to 2007
Gong YW, et al. J Bacteriol Virol. 2008 Dec;38(4):249-257. http://dx.doi.org/10.4167/jbv.2008.38.4.249